Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Hematology & Oncology|February 16, 2012
Current management and novel agents for malignant melanomaByung Lee, Nikhil Mukhi, Delong LiuCureus|October 19, 2022
Transient Sideroblastic Anemia Post-COVID-19 InfectionNikhil Mukhi, Luis R Soto, Aparna VuppalaJournal of Hematology & Oncology|October 13, 2012
Novel CD20 monoclonal antibodies for lymphoma therapyShundong Cang, Nikhil Mukhi, Kemeng Wang, et al.Biomarker Research|November 21, 2013
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical applicationMuhammad Furqan, Nikhil Mukhi, Byung Lee, et al.Journal of Hematology & Oncology|August 21, 2013
Ibrutinib and novel BTK inhibitors in clinical developmentAkintunde Akinleye, Yamei Chen, Nikhil Mukhi, et al.Journal of Hematology & Oncology|April 17, 2013
MEK and the inhibitors: from bench to bedsideAkintunde Akinleye, Muhammad Furqan, Nikhil Mukhi, et al.Journal of Hematology & Oncology|December 7, 2013
STAT inhibitors for cancer therapyMuhammad Furqan, Akintunde Akinleye, Nikhil Mukhi, et al.Hematology Reports|September 3, 2015
Chalazia Development in Multiple Myeloma: A New Complication Associated with Bortezomib TherapyCharles Yun, Nikhil Mukhi, Valerie Kremer, et al.American Journal of Therapeutics|May 17, 2014
The Conundrum of "Warfarin Hypersensitivity": Prolonged Partial Thromboplastin Time From Factor IX Propeptide MutationArunabh Sekhri, Adriana Lisinschi, Muhammad Furqan, et al.Journal of Patient Safety|February 14, 2014
Improving resident morning sign-out by use of daily events reportsChristopher Nabors, Dhruv Patel, Sahil Khera, et al.Pageof 1